Lv15
70 积分 2024-10-09 加入
Oral Abstracts
4天前
已完结
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
4天前
已完结
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
4天前
已完结
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
4天前
已完结
Once-Weekly Semaglutide in Adults with Overweight or Obesity
4天前
已完结
The Gut and Energy Balance: Visceral Allies in the Obesity Wars
4天前
已完结
The efficacy and safety of novel classes of glucose-lowering drugs for cardiovascular outcomes: a network meta-analysis of randomised clinical trials
17天前
已完结
Pathophysiology of Type 2 Diabetes Chapter First Online: 03 June 2023
17天前
已完结
Type 2 diabetes
17天前
已完结
皖公网安备34019202002308
